Benchmark Investment Advisors’s Broadcom AVGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.77M Buy
+18,641
New +$6.13M 3.35% 5
2025
Q3
$8.12M Buy
+24,601
New +$7.55M 4.72% 3
2025
Q1
$5.39M Buy
32,213
+6,924
+27% +$1.47M 3.49% 5
2024
Q4
$5.86M Sell
25,289
-689
-3% -$127K 3.82% 3
2024
Q3
$4.48M Buy
25,978
+908
+4% +$146K 3.19% 4
2024
Q2
$4.03M Sell
25,070
-460
-2% -$64.5K 2.91% 5
2024
Q1
$3.38M Sell
25,530
-1,930
-7% -$239K 2.67% 6
2023
Q4
$3.07M Buy
27,460
+2,080
+8% +$197K 2.84% 5
2023
Q3
$2.11M Buy
25,380
+1,570
+7% +$136K 2.13% 12
2023
Q2
$2.07M Buy
23,810
+1,430
+6% +$102K 1.9% 14
2023
Q1
$1.44M Sell
22,380
-1,230
-5% -$74K 1.47% 25
2022
Q4
$1.32M Buy
23,610
+12,590
+114% +$631K 1.39% 23
2022
Q3
$489K Buy
+11,020
New +$563K 0.53% 53

Other funds holding AVGO

Benchmark Investment Advisors's AVGO Position: Q1 2026 in Review

Benchmark Investment Advisors opened a new position in Broadcom (AVGO) in Q1 2026: 18,641 shares worth $5.77M. The stake represents 3.35% of the portfolio and ranks #5 among its holdings. This is a return to the name: Benchmark Investment Advisors previously reported a position in AVGO as recently as Q3 2025.

Benchmark Investment Advisors first reported a position in AVGO in Q3 2022 and has held it in 13 quarters since. The position peaked at $8.12M in Q3 2025. 4,664 funds tracked by Wall St. Rank hold AVGO as of Q1 2026.

  • Benchmark Investment Advisors held 18,641 shares of Broadcom worth $5.77M as of Q1 2026.
  • Broadcom was a new Benchmark Investment Advisors position in Q1 2026.
  • Broadcom made up 3.35% of Benchmark Investment Advisors's portfolio in Q1 2026, its #5 holding.
  • Benchmark Investment Advisors first reported a position in Broadcom in Q3 2022 and has held it in 13 quarters since.
  • Benchmark Investment Advisors's Broadcom position peaked at $8.12M in Q3 2025.
  • 4,664 funds tracked by Wall St. Rank held Broadcom as of Q1 2026.

Based on Benchmark Investment Advisors's 13F filing for Q1 2026, filed 13 May 2026.